Dr. Goldfarb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10515 W Santa Fe Dr
Sun City, AZ 85351Phone+1 623-832-6530
Education & Training
Brown University (Butler Hospital)Residency, Psychiatry/Neurology, 2012 - 2017
Brown UniversityResidency, Internal Medicine, 2011 - 2012
University of Arizona College of Medicine - PhoenixClass of 2011
Certifications & Licensure
AZ State Medical License 2018 - 2025
RI State Medical License 2011 - 2018- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 18
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 52 citationsMapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 DiseaseGeidy E. Serrano, Jessica E. Walker, Richard Arce, Michael J. Glass, Daisy Vargas
Medrxiv. 2021-02-18 - 91 citationsDeveloping retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forwardJessica Alber, Danielle Goldfarb, Louisa I. Thompson, Edmund Arthur, Kimberly A. Hernandez
Alzheimer's & Dementia. 2020-01-01 - 55 citationsDiagnosing and Treating Depression in Patients with Alzheimer's Disease.Anna D. Burke, Danielle Goldfarb, Padmaja Bollam, Sehar Khokher
Neurology and Therapy. 2019-08-21
Press Mentions
Clinical Trial Looking for Participants for New Alzheimer's DrugJanuary 25th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
